94 related articles for article (PubMed ID: 23900581)
1. Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA.
Parra E; Ferreira J
Oncol Rep; 2013 Oct; 30(4):1936-42. PubMed ID: 23900581
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells.
Parra E
Int J Mol Med; 2012 Oct; 30(4):923-30. PubMed ID: 22766602
[TBL] [Abstract][Full Text] [Related]
3. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
Lafarge S; Sylvain V; Ferrara M; Bignon YJ
Oncogene; 2001 Oct; 20(45):6597-606. PubMed ID: 11641785
[TBL] [Abstract][Full Text] [Related]
5. Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity.
Inostroza J; Sáenz L; Calaf G; Cabello G; Parra E
Biol Res; 2005; 38(2-3):163-78. PubMed ID: 16238095
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines.
Parra E; Ferreira J; Ortega A
Int J Oncol; 2011 Aug; 39(2):345-52. PubMed ID: 21617851
[TBL] [Abstract][Full Text] [Related]
7. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells.
Parra E; Gutiérrez L; Ferreira J
Oncol Rep; 2015 Jan; 33(1):413-8. PubMed ID: 25351964
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor.
Parra E; Gutiérrez L; Ferreira J
Oncol Rep; 2013 Aug; 30(2):911-6. PubMed ID: 23715767
[TBL] [Abstract][Full Text] [Related]
10. JNK is required for maintaining the tumor-initiating cell-like properties of acquired chemoresistant human cancer cells.
Liu Y; Zhang X; Wang J; Yang J; Tan WF
Acta Pharmacol Sin; 2015 Sep; 36(9):1099-106. PubMed ID: 26235742
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells.
Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
J Urol; 2005 Nov; 174(5):2022-6. PubMed ID: 16217386
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression.
Min L; Chen Q; He S; Liu S; Ma Y
Mol Med Rep; 2012 Jan; 5(1):228-32. PubMed ID: 21964646
[TBL] [Abstract][Full Text] [Related]
13. [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines].
Liu GY; Qu QX; Mi RR; Qi J
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):339-42. PubMed ID: 16762192
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells.
Zhang XY; Wu XQ; Deng R; Sun T; Feng GK; Zhu XF
Cell Signal; 2013 Jan; 25(1):150-8. PubMed ID: 22982090
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells.
Sun B; Zhang X; Yonz C; Cummings BS
Biochem Pharmacol; 2010 Jun; 79(12):1727-35. PubMed ID: 20171194
[TBL] [Abstract][Full Text] [Related]
16. Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.
Gan L; Wang J; Xu H; Yang X
Prostate; 2011 Aug; 71(11):1158-66. PubMed ID: 21656826
[TBL] [Abstract][Full Text] [Related]
17. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
18. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
19. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
Parra E; Ferreira J; Saenz L
Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
